Jefferson to Host Second Annual Alzheimers Disease
Conference for Caregivers
We are holding our annual conference not only to share new developments in the area of Alzheimers disease, but to show our continuing support for the hard work and dedication provided by caregivers, said Patricio Reyes, MD, Director of the Jefferson Alzheimers Disease and Dementia Center, Professor of Neurology, Jefferson Medical College. Topics to be discussed include coping with caregiver stress, acute and chronic care and treatment options for patients with Alzheimers disease.
The Alzheimers Disease and Dementia Center was established in 1982 at Jefferson Hospital. The center has quickly distinguished itself as a leader in the investigation and treatment of neurological disorders primarily striking older adults. Through the center, Jefferson offers clinical and educational services to individuals and their family members who are struggling with Alzheimers and other forms of dementia. A referral network is being developed for patients and their families in need of support services.
To register for the conference, or to obtain more information about Jeffersons Alzheimer Center, please call 215-955-8119.
Learn How to Prevent Domestic Violence
New Electrical Generation Agreement Saves Millions
National Institutes of Health Awards Two Grants to
The first award goes to Sergio Jimenez, MD, Chairman, Division of Rheumatology, Department of Medicine, Thomas Jefferson University Hospital (TJUH), and the Dorrance H. Hamilton Professor of Medicine and Professor of Biochemistry and Molecular Pharmacology, Jefferson Medical College (JMC), Thomas Jefferson University (TJU). This grant is a continuation of a previous grant for a research project to study an animal model which reproduces the clinical characteristics of scleroderma. This new phase of the project will focus on how a gene mutation found in mice can produce the phenotype of scleroderma. Also working with Dr. Jimenez is Linda Siracusa, PhD, Associate Professor of Microbiology and Immunology, JMC, TJU and Researcher, Kimmel Cancer Center.
The second grant was awarded to another Scleroderma study headed by Carol Artlett, PhD,
Research Assistant Professor, Division of Rheumatology, Department of Medicine, TJUH. This
project is based on preliminary studies done at Jefferson which suggest that fetal cells
remaining dormant in a womans body after pregnancy may be capable of attacking her
tissues and causing scleroderma later in life if a trigger mechanism is present. Dr.
J. Bruce Smith, MD, Division of Rheumatology, Department of Medicine, TJUH, and Professor of Medicine, JMC, TJU, and Dr. Jimenez.